Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000008651
JPRN-UMIN000008651
Not yet recruiting
未知

Study examining the PROMUS Element everolimus-eluting stent in multi-center Coronary Intervention of complex Arterial Lesion Subsets - SPECIALIST registry

The PCI Guideline Research Society0 sites800 target enrollmentAugust 10, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
The PCI Guideline Research Society
Enrollment
800
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 10, 2012
End Date
June 30, 2015
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The PCI Guideline Research Society

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1\) Hypersensitivity to cobalt chromium, everolimus, heparin, aspirin, ticlopidine, clopidogrel or X\-ray contrast media. 2\) Serum creatinine level \>3\.0 mg/dL 3\) Other concomitant disease or medical condition that could impact patient/procedural outcomes, such as history of bleeding diathesis or cancer within 5 years.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Study examining the PROMUS Element everolimus-eluting stent in multi-center Coronary Intervention of complex Arterial Lesion Subsets (OCT and IVUS sub analysis)Complex coronary artery disease
JPRN-UMIN000021122The PCI Guideline Research Society50
Completed
Phase 4
PE-Prove Study PROMUS* Element* Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study A prospective, open label, multi-center observational study
NL-OMON34092Boston Scientific International S.A.90
Unknown
Not Applicable
Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion SubsetsCoronary Artery Disease
NCT01670318The PCI Guideline Research Society800
Completed
Phase 3
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)Coronary Artery Disease
NCT01500434Boston Scientific Corporation102
Completed
Not Applicable
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small VesselsCoronary Artery Disease
NCT01498692Boston Scientific Corporation94